-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - criteria: (1) appropriateness of the randomization scheme, (2) appropriateness of the
blinding, and (3) description … concepts of high quality, including the
following: a formal randomized controlled design; a clear description
-
effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
January 01, 2011 - The supplement concludes with a description of how Directed Acyclic Graphs (DAGs)
can be used to select … The supplement
concludes with a description of how Directed Acyclic
Graphs (DAGs) can be used to select
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
May 24, 2010 - held concepts of high quality
including the following: a formal randomized controlled study; clear description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - author, year of
publication, study location (e.g., country, city, state) and time period, population description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
March 07, 2012 - None of the studies looked specifically at children with
joint swelling; we added this to the description … operating characteristic curve for different tests and
diagnoses could be improved with a detailed figure
description … We have reworded the outcome description for KQ5.